[{"id":"4c05af61-5d05-4c37-bd6c-572d69e5c509","acronym":"BETA-PRIME","url":"https://clinicaltrials.gov/study/NCT04673942","created_at":"2024-02-16T15:19:06.027Z","updated_at":"2024-07-02T16:35:04.617Z","phase":"Phase 2","brief_title":"A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors","source_id_and_acronym":"NCT04673942 - BETA-PRIME","lead_sponsor":"EpicentRx, Inc.","biomarkers":" TGFB1","pipe":"","alterations":" ","tags":["TGFB1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e AIM-001"],"overall_status":"Recruiting","enrollment":" Enrollment 140","initiation":"Initiation: 03/29/2021","start_date":" 03/29/2021","primary_txt":" Primary completion: 12/01/2025","primary_completion_date":" 12/01/2025","study_txt":" Completion: 03/01/2027","study_completion_date":" 03/01/2027","last_update_posted":"2024-05-09"}]